CT antigen TCR-engineered T cells

· Adaptimmune

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT antigen TCR-engineered T cells, covering 2018-07-24 to 2018-07-24. Get the full timeline:

Most recent: Clinical Trial Update: CT Antigen TCR-Engineered T Cells for Myeloma [Phase 1, Phase 2]